SavvY logo
flag US
Biochimpharm.png

Biochimpharm Financial Model

BCP.jpg

Biochimpharm

Biochimpharm is a biotechnology company specializing in the production of bacteriophage-based medicines aimed at combating bacterial infections. The company focuses on advancing long-term expertise in phage therapy to provide safe and effective alternatives to antibiotics.

SavvY created a financial model for a new production unit of Biochimpharm and evaluated the existing project, including investment volume, assumptions, profitability, cost structure, and revenue projections. Using a five-year financial model, the project was assessed reliably for presentation to investors.

Services

Business Plan

Worked on

Date

2017

Country

Flag_of_Georgia.svg.png

Georgia